Quince Therapeutics, Inc. (QNCX): SC 13D filed Nov 13, 2024

Form type

SC 13D

Filing date

Nov 13, 2024

Accession number

0001193125-24-257646

Filer

Quince Therapeutics, Inc. (CIK 1662774)